These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 25280769)

  • 1. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for preventing late postnatal mother-to-child transmission of HIV.
    Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
    Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE
    N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
    Coovadia HM; Brown ER; Fowler MG; Chipato T; Moodley D; Manji K; Musoke P; Stranix-Chibanda L; Chetty V; Fawzi W; Nakabiito C; Msweli L; Kisenge R; Guay L; Mwatha A; Lynn DJ; Eshleman SH; Richardson P; George K; Andrew P; Mofenson LM; Zwerski S; Maldonado Y;
    Lancet; 2012 Jan; 379(9812):221-8. PubMed ID: 22196945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
    Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
    PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
    Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
    Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.